Physiotherapists prescribing medications to manage pain in emergency departments and outpatient clinics
In patients presenting to emergency departments or orthopaedic clinics with musculoskeletal conditions, does physiotherapists prescribing medications to manage pain result in adverse events?
QEII Jubilee Hospital
2,500 participants
May 11, 2017
Interventional
Conditions
Summary
This study aims to investigate the safety and patient experience of prescribing by credentialed physiotherapists. Patients attending emergency departments and outpatient clinics with musculoskeletal conditions will be prescribed medications from a limited list to manage pain and support physiotherapy treatment.
Eligibility
Plain Language Summary
Simplified for easier understanding
This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Assessment and management of patient presentation in accordance with clinical guidelines by physiotherapists in the emergency department or orthopaedic clinic. This may involve mobilisation, massage, exercise therapy, stretches, advice and provision of the following medications, at the discretion of the physiotherapist, for the management of pain: Paracetamol (oral tablet) Paracetamol and Codeine (oral tablet) Diclofenac sodium (oral tablet) Lignocaine 1 or 2% (subcutaneous or intra-articular injection) Nitrous Oxide up to 70% (inhaled gas) Ibuprofen (oral tablet) Betamethasone injection 5.7mg/ml (intra-articular injection) Methylprednisolone acetate 40mg/ml 1ml (intra-articular injection) Amitriptyline hydrochloride (oral tablet)
Locations(5)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12615000525583